Practices, Efficacy, and Reported Side Effects Associated with Isotretinoin Treatment in Palestine

References

• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.e33. doi:10.1016/j.jaad.2015.12.037
   PubMed Web of Science ®Google Scholar
• Bagatin E, Costa CS. The use of Isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects. Expert Rev Clin Pharmacol. 2020;13(8):885–897. doi:10.1080/17512433.2020.1796637
   PubMed Web of Science ®Google Scholar
• Nickle SB, Peterson N, Peterson M. Updated physician’s guide to the off-label uses of oral isotretinoin. J Clin Aesthet Dermatol. 2014;7(4):22–34.
   PubMedGoogle Scholar
• Leyden JJ, Rosso JQ D, Baum EW, Mcguigan KA. Faculty the use of Isotretinoin in the treatment of acne vulgaris clinical considerations and future directions. J Clin Aesthet Dermatol. 2014;7(2 Suppl):S3.
   PubMedGoogle Scholar
• Chernyshov PV, Tomas-Aragones L, Manolache L, et al. Which acne treatment has the best influence on health-related quality of life? Literature review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol. 2018;32(9):1410–1419. doi:10.1111/jdv.15048
   PubMed Web of Science ®Google Scholar
• Karaosmanoğlu N, Mülkoğlu C. Analysis of musculoskeletal side effects of oral Isotretinoin treatment: a cross-sectional study. BMC Musculoskelet Disord. 2020;21(1):631. doi:10.1186/s12891-020-03656-w
   PubMed Web of Science ®Google Scholar
• Acne clinical guideline. Available from: https://www.aad.org/member/clinical-quality/guidelines/acne. Accessed September 20, 2023.
   Google Scholar
• British Association of Dermatologists. Isotretinoin patient guide. Available from: https://www.bad.org.uk/pils/isotretinoin/. Accessed September 20, 2023.
   Google Scholar
• Caffery BE, Josephson JE. Ocular side effects of isotretinoin therapy. J Am Optom Assoc. 1988;59(3):221–224.
   PubMedGoogle Scholar
• Azoulay L, Oraichi D, Bérard A. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern? Eur J Clin Pharmacol. 2006;62(8):667–674. doi:10.1007/S00228-006-0151-X/METRICS
   PubMed Web of Science ®Google Scholar
• Tang MBY, Tan EST, Tian EAL, Loo SC, Chua SH. Electronic e-isotretinoin prescription chart: improving physicians’ adherence to isotretinoin prescription guidelines. Australas J Dermatol. 2009;50(2):107–112. doi:10.1111/j.1440-0960.2009.00516.x
   PubMed Web of Science ®Google Scholar
• Lelubre M, Hamdani J, Senterre C, et al. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: survey among French-speaking health care professionals and patients in Belgium. Pharmacoepidemiol Drug Saf. 2018;27(6):668–673. doi:10.1002/pds.4441
   PubMed Web of Science ®Google Scholar
• Huang YC, Cheng YC. Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;76(6):1068–1076.e9. doi:10.1016/j.jaad.2016.12.028
   PubMed Web of Science ®Google Scholar
• Albadr T, Alruhaimi D, Cahusac PB, Rohra D. Knowledge and use of isotretinoin in Saudi female college students: cross -sectional study. J Dermatol Dermatologic Surg. 2019;23(2):76. doi:10.4103/jdds.jdds_2_19
   Web of Science ®Google Scholar
• Jarab AS, Al-Azzam S, Almutairi S, Mukattash TL. Patients’ knowledge and information needs about isotretinoin therapy use in Jordan. Int J Clin Pract. 2022;2022:1–6. doi:10.1155/2022/9443884
   Web of Science ®Google Scholar
• Isotretinoin: the truth about side effects. Available from: https://www.aad.org/public/diseases/acne/derm-treat/isotretinoin/side-effects. Accessed August 31, 2023.
   Google Scholar
• Younis NS, Al-Harbi NY. Public understanding and awareness of isotretinoin use and safety in Al Ahsa, Eastern Saudi Arabia. Ther Innov Regul Sci. 2019;53(5):618–622. doi:10.1177/2168479018807677
   PubMed Web of Science ®Google Scholar
• Bakheet KMA, Alghanemi RG, Alsiyoufi AM, Abduljabbar M, Hariri J. Females’ knowledge and use of isotretinoin (Roaccutane) in the Western Region of Saudi Arabia. Cureus. 2020. doi:10.7759/cureus.12148
   Web of Science ®Google Scholar
• Reserva J, Adams W, Perlman D, et al. Coprescription of Isotretinoin and tetracyclines for acne is rare: an analysis of the National Ambulatory Medical Care Survey. J Clin Aesthet Dermatol. 2019;12(10):45–48.
   PubMedGoogle Scholar
• Shin J, Cheetham TC, Wong L, et al. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol. 2011;65(6):1117–1125. doi:10.1016/j.jaad.2010.09.017
   PubMed Web of Science ®Google Scholar
• Crijns HJMJ, van Rein N, Gispen-de Wied CC, Straus SM, de Jong-van den Berg LTW. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study. Pharmacoepidemiol Drug Saf. 2012;21(10):1060–1066. doi:10.1002/pds.3200
   PubMed Web of Science ®Google Scholar
• Autret-Leca E, Kreft-Jais C, Elefant E, et al. Isotretinoin exposure during pregnancy. Drug Saf. 2010;33(8):659–665. doi:10.2165/11536250-000000000-00000
   PubMed Web of Science ®Google Scholar
• Bhat R, Nandakishore B, Dandakeri S, Martis J, Kamath G, Rao P. Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris. Indian J Dermatol. 2014;59(3):316. doi:10.4103/0019-5154.131455
   PubMed Web of Science ®Google Scholar
• Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Isotretinoin. Drugs. 1984;28(1):6–37. doi:10.2165/00003495-198428010-00002
   PubMed Web of Science ®Google Scholar
• Lytvyn Y, McDonald K, Mufti A, Beecker J. Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: a systematic review. JAAD Int. 2022;6:125–142. doi:10.1016/j.jdin.2022.01.002
   PubMedGoogle Scholar
• Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen Effluvium: a Review of the Literature. Cureus. 2020. doi:10.7759/cureus.8320
   Web of Science ®Google Scholar
• Crandall J, Sakai Y, Zhang J, et al. 13- cis -retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci. 2004;101(14):5111–5116. doi:10.1073/pnas.0306336101
   PubMed Web of Science ®Google Scholar
• Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009;1(3):162–169. doi:10.4161/derm.1.3.9364
   PubMedGoogle Scholar
• O’Reilly K, Bailey SJ, Lane MA. Retinoid-mediated regulation of mood: possible cellular mechanisms. Exper Biol Med. 2008;233(3):251–258. doi:10.3181/0706-MR-158
   Web of Science ®Google Scholar
• Oliveira JM, Sobreira G, Velosa J, Telles Correia D, Filipe P. Association of isotretinoin with depression and suicide: a review of current literature. J Cutan Med Surg. 2018;22(1):58–64. doi:10.1177/1203475417719052
   PubMed Web of Science ®Google Scholar
• Marron S, Tomas-Aragones L, Boira SA. Depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin. Acta Dermatol Venereologica. 2013;93(6):701–706. doi:10.2340/00015555-1638
   PubMed Web of Science ®Google Scholar
• Suarez B, Serrano A, Cova Y, Baptista T. Isotretinoin was not associated with depression or anxiety: a twelve-week study. World J Psychiatry. 2016;6(1):136. doi:10.5498/wjp.v6.i1.136
   PubMedGoogle Scholar
• Sundstrom A, Alfredsson L, Sjolin-Forsberg G, Gerden B, Bergman U, Jokinen J. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ. 2010;341(1):c5812. doi:10.1136/bmj.c5812
   PubMedGoogle Scholar
• Kapała J, Lewandowska J, Placek W, Owczarczyk-Saczonek A. Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis. Int J Environ Res Public Health. 2022;19(11):6463.
   PubMed Web of Science ®Google Scholar
• Sarkar T, Sarkar S, Patra A. Low-dose isotretinoin therapy and blood lipid abnormality: a case series with sixty patients. J Family Med Prim Care. 2018;7(1):171. doi:10.4103/jfmpc.jfmpc_104_16
   PubMedGoogle Scholar
• Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Med Nov Technol Devices. 2019;4:100025. doi:10.1016/j.medntd.2019.100025
   Google Scholar
• Morales-Cardona CA, Sánchez-Vanegas G. Acne relapse rate and predictors of relapse following treatment with oral isotretinoin. Actas Dermo-Sifiliográficas. 2013;104(1):61–66. doi:10.1016/j.adengl.2012.05.021
   PubMedGoogle Scholar
• Sa A, Y A, Am A, Sa A, L P, Na A. Prevalence and associated risk factors of acne relapse among Saudi acne vulgaris patients using isotretinoin. Saudi Pharm J. 2020;28(3):374–379. doi:10.1016/j.jsps.2020.01.019
   PubMed Web of Science ®Google Scholar
• Harms M, Masouyé I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study. Dermatologica. 1986;172(3):148–153. doi:10.1159/000249320
   PubMedGoogle Scholar
• Azoulay L, Oraichi D, Bérard A. Isotretinoin therapy and the incidence of acne relapse: a nested case–control study. Br J Dermatol. 2007;157(6):1240–1248. doi:10.1111/j.1365-2133.2007.08250.x
   PubMed Web of Science ®Google Scholar
• Elsaie ML. Hormonal treatment of acne vulgaris: an update. Clin Cosmet Invest Dermatol. 2016;9:241–248. doi:10.2147/CCID.S114830
   PubMed Web of Science ®Google Scholar
• Leyden JJ. Oral Isotretinoin. Dermatology. 1997;195(1):29–33. doi:10.1159/000246017
   PubMedGoogle Scholar